PRSS22 and neoplasm: Thus, by combining the result of analysis of the two biomarkers - one detecting tumor cells in LNs derived from the large intestine (i.e., CEA) and one detecting a secreted protease (i.e., PRSS22), 64%, (22/34) of the patients that died of CC during the 12 years after operation were found in the marker positive group.